Click here to view online. Add this email to your safelist.
Uniting human and machine intelligence for drug discovery
8 April 2021
What Science Can Do: New story alert
Working side-by-side in joint multidisciplinary teams, with leading expertise in drug discovery and disease understanding from AstraZeneca, and ground-breaking proprietary technology from BenevolentAI, we are evolving drug discovery for some of the world’s most complex biological challenges.
|
|||||
|
|||||
|
For more information please visit astrazeneca.com. If you would like to unsubscribe please click here. |
